EU could block vaccine export amid a shortage of AstraZeneca’s COVID-19 shots

Source: Juan Roballo, Shutterstock

Summary

  • With vaccination programs in Britain and the US moving far ahead, EU leaders have warned to block the vaccine supply.
  • The EU stated that AstraZeneca intends to deliver just 100 million out of 300 million to be delivered by June 2021.
  • If the European Union blocks vaccine shipments overseas, it could provoke conflicts with the UK.

EU leaders voiced disappointment on 25 March 2021 for a substantial shortage in contracted deliveries of Oxford-AstraZeneca’s COVID-19 vaccines, while the third wave of infections surged in the European nations.

With immunisation programs moving far behind from Britain and the US, the Executives warn that they would block COVID-19 vaccine exports by AstraZeneca until the Company provides the vaccine shots as pledged to the European Union (EU). The EU has only administered 14 jabs for every 100 people, while the UK has administered 46 per 100.

Moreover, AstraZeneca promised to deliver 300 million vaccine shots to EU nations by the end of June 2021 but now intends to provide only 100 million.

ALSO READ: EU faces AstraZeneca’s COVID-19 vaccine shortage amid manufacturing concerns

The European Commission warned to unveil plans to block the vaccine shipment to nations with higher vaccination rate, as the third wave of coronavirus infection has been surging in Europe.

The third wave of infections has been rising in the EU (Copyright © 2021 Kalkine Media Pty Ltd)

EC’s President Ursula von der Leyen stated:

EU warns to ban the export of AstraZeneca’s vaccine

In the EU, the vaccinations drive is running behind from the US and the UK. With the rising cases of COVID-19 in the third wave, the leaders are advising to block the vaccine export if the vaccine developer fails to deliver the shots as promised. 

Moreover, the European Commission’s plan to tighten vaccine exports would allow greater scope to block shipments to countries with higher vaccination rates.

The troubled vaccine rollout in the European Union has led to a dispute with Britain. As per the EU official, Britain has imported 21 million doses manufactured in Europe.

However, Britain stated that the country did an excellent job negotiating with the vaccine developers and arranging supply chains for them.

If the European Union decides to block shipments overseas, it could provoke conflicts with the UK.

ALSO READ: Two COVID-19 vaccines that are helping the world get over the pandemic

 


Disclaimer
The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. (Kalkine Media) A.C.N. 629 651 672. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK